NorthWest Biotherapeutics Inc (NWBO)

[MI Dendream]

Would you go after the full market potential of the GBM SOC which probably runs at 80-85% of all diagnosed, OR, would you want at best half of the patients that progress on the SOC, maybe 20-25% of the full market?

Seems like a lot of guacamole to me. Mucho bueno, guacamole con limon y tequila privada.

The current market estimate will grow substantially when a significant advance is offered. That is a lot of fresh guacamole we bought with those extra years. A whole lot of guacamole.

For simplification…

$5-6B x 0.75 = X 5 yrs =
$3.5B x 0.2 = X 9 years =

A whole lot of guacamole